By integrating clinical, genetic, and other data from patients with lung cancer, researchers identify biological factors that could help predict treatment outcomes.
Nominations are now open for the first award of the Richard N. Merkin Prize in Biomedical Technology, which recognizes novel technologies that have improved human health.
Researchers will analyze the DNA of tens of thousands of people from five countries in East and South Asia to find genetic markers for the psychiatric condition.
A new technology called RADARS allows scientists to detect and target specific cell types, opening up potential applications in diagnostics and therapeutics.
A single-cell analysis of 3D models of the human cerebral cortex suggests they can be used to study important brain processes that have been difficult to investigate.
New method finds compounds that bind and inhibit individual members of a family of key regulatory proteins, called cyclophilins, that have been difficult to target selectively.
Addition of six-story facility will bring Broad’s footprint in Kendall to nearly one million square feet, significantly increasing lab space for scientific innovation